tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CFRX

CFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsCFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
CFRX
ContraFect files to sell $15M of common stock, Class E warrants
PremiumThe Fly
ContraFect files to sell $15M of common stock, Class E warrants
1y ago
CFRX
ContraFect files to sell 7.03M shares of common stock for holders
PremiumThe Fly
ContraFect files to sell 7.03M shares of common stock for holders
1y ago
CFRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
ALDX
APLT
ContraFect announces FDA clearance of CF-370 IND application
PremiumThe Fly
ContraFect announces FDA clearance of CF-370 IND application
1y ago
CFRX
option delistings on September 25th
PremiumThe Flyoption delistings on September 25th
1y ago
MFH
NYC
ContraFect announces submission of IND application to FDA for CF-370
Premium
The Fly
ContraFect announces submission of IND application to FDA for CF-370
1y ago
CFRX
ContraFect reports Q2 EPS ($1.94) vs ($36.79) last year
Premium
The Fly
ContraFect reports Q2 EPS ($1.94) vs ($36.79) last year
1y ago
CFRX
ContraFect enters warrant exercise transaction for $9.6M in proceeds
PremiumThe Fly
ContraFect enters warrant exercise transaction for $9.6M in proceeds
1y ago
CFRX
ContraFect announces presentation of data at ASM Microbe 2023
PremiumThe Fly
ContraFect announces presentation of data at ASM Microbe 2023
1y ago
CFRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
CFRX
MRKR
ContraFect Gains with Key Data Presentation Set for Next Week
PremiumMarket News
ContraFect Gains with Key Data Presentation Set for Next Week
1y ago
CFRX
ContraFect announces first patient dosed in Phase 1b/2 study of exebacase
PremiumThe FlyContraFect announces first patient dosed in Phase 1b/2 study of exebacase
2y ago
CFRX
ContraFect presents CF-370 data at annual EECMID meeting
Premium
The Fly
ContraFect presents CF-370 data at annual EECMID meeting
2y ago
CFRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2y ago
MRK
BLCM
ContraFect upgraded to Buy from Hold at Maxim
PremiumThe Fly
ContraFect upgraded to Buy from Hold at Maxim
2y ago
CFRX
ContraFect announces initiation of Phase 1b/2 study of exebacase
PremiumThe Fly
ContraFect announces initiation of Phase 1b/2 study of exebacase
2y ago
CFRX
ContraFect reports Q4 EPS ($16.14) vs. ($8.95) last year
PremiumThe Fly
ContraFect reports Q4 EPS ($16.14) vs. ($8.95) last year
2y ago
CFRX
ContraFect announces database lock, interim results from DISRUPT study
PremiumThe Fly
ContraFect announces database lock, interim results from DISRUPT study
2y ago
CFRX
ContraFect announces pricing of $7M registered directoffering
PremiumThe FlyContraFect announces pricing of $7M registered directoffering
2y ago
CFRX
ContraFect announces ANSM approval of CTA for exebacase
Premium
The Fly
ContraFect announces ANSM approval of CTA for exebacase
2y ago
CFRX
2 “Strong Buy” Penny Stocks With Massive Upside Potential
Premium
Stock Analysis & Ideas
2 “Strong Buy” Penny Stocks With Massive Upside Potential
3y ago
CFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >